Scientists have developed smart nanoparticles designed to both illuminate and destroy glioblastoma cells, a deadly form of brain cancer. The treatment, tested on mice, demonstrated a 100% survival rate at 60 days by targeting cancer cells missed during surgery and preventing recurrence.
The new approach addresses a critical challenge in treating glioblastoma, a particularly aggressive cancer. Researchers created nanoparticles capable of lighting up hidden glioblastoma cells during surgical procedures, aiding in more complete removal. Crucially, the nanoparticles also destroy microscopic cancer cells that often remain after surgery – the primary cause of recurrence.
In testing on mice, the treatment proved remarkably effective. According to the source, the treatment led to 100% survival at 60 days. This success is attributed to the nanoparticles’ dual function of illuminating and eliminating residual cancer cells. While promising, it is important to note that the treatment has not yet been tested on humans.
The scientists hope this technology will significantly improve outcomes for patients diagnosed with glioblastoma, a cancer with a historically poor prognosis. The ability to both visualize and destroy remaining cancer cells offers a potential breakthrough in treatment strategies.
Read the original coverage
💬 Comments
📜 Comment Policy